AHA, FAH report documents dramatic rise in inpatient drug costs

AHA News

Inpatient hospital drug costs increased more than 38% per admission between 2013 and 2015, according to a report from the University of Chicago’s NORC, an independent research institution. The report was commissioned by the AHA and Federation of American Hospitals (FAH), who unveiled its findings at an... read more

Topic: Advocacy and Public Policy
Tag: drug prices

AHA, FAH report documents dramatic rise in inpatient drug costs

AHA News Now

Inpatient hospital drug costs increased more than 38% per admission between 2013 and 2015, according to a new report from the University of Chicago’s NORC, an independent research institution. According to the analysis of inpatient drug pricing data from 712 community hospitals and two group purchasing... read more

Topic: Advocacy and Public Policy
Tag: drug prices

AHA, AHIP CEOs promote strong and stable exchanges

AHA News Now

AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner today called for “value-based solutions” that promote strong, stable and affordable health insurance coverage through the insurance exchanges. In an op-ed piece in The Hill, a Capitol Hill newspaper,... read more

Topic: Advocacy and Public Policy
Tags: Coverage, drug prices

House committee holds hearing on rising price of drug-injecting device

AHA News Now

The House Committee on Oversight and Government Reform yesterday held a hearing on the rising price of a device used to inject the drug epinephrine to treat severe allergic reactions. While the EpiPen Auto-Injector has been on the market since 1988, the price for a two-pack of the devices has increased... read more

Topic: Advocacy and Public Policy
Tag: drug prices

GAO: Prices for more than 300 Part D generic drugs surge over five years

AHA News Now

More than 300 established generic drugs under Medicare Part D had at least one price increase of 100% or more between first-quarter 2010 and first-quarter 2015, according to a report released yesterday by the Government Accountability Office. While prices for a changing basket of 2,378 Part D generic... read more

Topic: Advocacy and Public Policy
Tags: Medicare, drug prices

Study looks at policy options to contain high prescription drug costs

AHA News Now

According to a study published today in the Journal of the American Medical Association, the most realistic short-term strategies to address high U.S. prescription drug prices include enforcing more stringent requirements for the award and extension of exclusivity rights; enhancing competition by ensuring... read more

Topic: Advocacy and Public Policy
Tag: drug prices

CMS: Part D drug costs up 17% in 2014

AHA News Now

Prescription drug claims for the 38 million beneficiaries in Medicare Advantage and stand-alone prescription drug plans rose by 3.3% in 2014, while drug costs for the program rose by 17% to $121 billion, according to data released today by the Centers for Medicare & Medicaid Services. Total annual costs... read more

Topic: Advocacy and Public Policy
Tag: drug prices

Coalition briefs Congress on proposals to rein in soaring drug prices

AHA News Now

The Campaign for Sustainable Rx Pricing yesterday held a Capitol Hill briefing and panel discussion on market-based solutions to the nation’s soaring prescription drug prices. “This is a public health crisis….with the health of real patients at stake,” said John Lewin, director of the critical care and... read more

Topic: Advocacy and Public Policy
Tag: drug prices

Senate Judiciary Committee holds hearing on CREATES Act

AHA News Now

The Senate Judiciary Committee today held a hearing on the Creating and Restoring Equal Access to Equivalent Samples Act, AHA-supported legislation that targets anticompetitive behaviors used to block and delay entry of generic drugs. The bipartisan legislation would allow a generic drug manufacturer... read more

Topic: Advocacy and Public Policy
Tags: advocacy, drug prices

AHA voices support for CREATES Act

AHA News Now

The AHA yesterday expressed support for the Creating and Restoring Equal Access to Equivalent Samples Act, which targets anticompetitive behaviors used to block and delay entry of generic drugs. The bipartisan legislation would allow a generic drug manufacturer facing one of these delay tactics to bring... read more

Topic: Advocacy and Public Policy
Tag: drug prices

Keyword Search

Date